We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Alimera Sciences Inc | NASDAQ:ALIM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 2.74% | 3.75 | 3.57 | 4.00 | 3.9859 | 3.57 | 3.60 | 99,562 | 01:00:00 |
Delaware
(State or other jurisdiction of incorporation or organization)
|
|
20-0028718
(IRS Employer
Identification No.)
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
x
|
Title of Securities to be Registered
|
|
Amount to be Registered(1)
|
|
Proposed Maximum Offering Price per Share
|
|
Proposed Maximum Aggregate Offering Price
|
|
Amount of Registration Fee
|
|
|
|
|
|
|
|
|
|
Options and Rights to Purchase Common Stock
|
|
2,000,000
|
|
N/A
|
|
N/A
|
|
N/A
|
Options and Rights to Purchase Common Stock
|
|
82,760
|
|
N/A
|
|
N/A
|
|
N/A
|
Common Stock,
$0.01
par value
|
|
2,000,000 shares
|
|
$1.13
|
|
$2,260,000.00
|
|
$261.93
|
Common Stock,
$0.01
par value
|
|
82,760 shares
|
|
$1.13
|
|
$93,518.80
|
|
$10.84
|
(1)
|
The shares registered hereunder include (i) 2,000,000 shares of Common Stock reserved for issuance pursuant to the Alimera Sciences, Inc. 2010 Equity Incentive Plan (the “2010 EIP”) and (ii) 82,760 shares of Common Stock reserved for issuance pursuant to the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan (the “2010 ESPP”). This Registration Statement shall also cover any additional shares of Common Stock which become issuable under the 2010 EIP and the 2010 ESPP by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock of Alimera Sciences, Inc.
|
(2)
|
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and (h)(1) under the Securities Act of 1933, as amended. The offering price per share and aggregate offering price for the unissued stock options and shares of Common Stock are based upon the average of the high and low prices of the Registrant’s common stock as reported on The NASDAQ Global Market on January 3, 2017.
|
Item 3.
|
Incorporation of Documents by Reference
|
(a)
|
The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on
March 15
, 2016, pursuant to the Securities Exchange Act of 1934, as amended (the “1934 Act”);
|
(b)
|
The Registrant’s Quarterly Reports on Form 10-Q filed with the SEC on May 6, 2016, August 5, 2016 and November 4, 2016, pursuant to the 1934 Act;
|
(c)
|
The Registrant’s Current Reports on Form 8-K filed with the SEC on February 5, 2016, March 3, 2016, March 7, 2016, March 8, 2016, March 14, 2016, May 5, 2016, May 27, 2016, June 27, 2016, July 12, 2016, July 26, 2016, August 4, 2016, August 10, 2016, August 11, 2016, October 20, 2016, November 3, 2016 and November 16, 2016, each only to the extent filed and not furnished; and
|
(d)
|
The description of the Registrant’s outstanding Common Stock contained in the Registrant’s Registration Statement No. 001-34703 on Form 8-A filed with the SEC on April 19, 2010, pursuant to Section 12 of the 1934 Act, including any amendment or report filed for the purpose of updating such description.
|
Item 4.
|
Description of Securities
|
Item 5.
|
Interests of Named Experts and Counsel
|
Item 6.
|
Indemnification of Directors and Officers
|
Item 7.
|
Exemption from Registration Claimed
|
Item 8.
|
Exhibits
|
Exhibit Number
|
Exhibit
|
4.1
|
Restated Certificate of Incorporation of the Registrant (Incorporated herein by reference to Registrant’s Registration Statement on Form S-1/A (File No. 333-162782, Exhibit 3.2) filed with the SEC on April 6, 2010).
|
4.2
|
Amended and Restated Bylaws of the Registrant, as amended (Incorporated herein by reference to Registrant's Current Report (File No. 001-34703, Exhibit 3.1) filed with the SEC on November 5, 2015).
|
4.3
|
Form of Certificate of Designation (Incorporated herein by reference to Registrant’s Current Report (File No. 001-34703, Exhibit 3.5) filed with the SEC on October 2, 2012).
|
4.4
|
Certificate of Designation (Incorporated herein by reference to Registrant’s Current Report (File No. 001-34703, Exhibit 3.6) filed with the SEC on December 15, 2014).
|
4.5
|
Certificate of Amendment to the Restated Certificate of Incorporation of the Registrant.
|
5.1
|
Opinion and consent of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP.
|
23.1
|
Consent of Grant Thornton LLP, Independent Registered Public Accounting Firm.
|
23.2
|
Consent of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is contained in Exhibit 5.1.
|
24.1
|
Power of Attorney. Reference is made to page II-5 of this Registration Statement.
|
99.1
|
Alimera Sciences, Inc. 2010 Equity Incentive Plan (Incorporated herein by reference to Registrant’s Registration Statement on Form S-8 (File No. 333-166822, Exhibit 99.3) filed with the SEC on May 14, 2010).
|
99.2
|
Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan (Incorporated herein by reference to Registrant’s Registration Statement on Form S-8 (File No. 333-166822, Exhibit 99.4) filed with the SEC on May 14, 2010).
|
99.3
|
Amendment No. 1 to 2010 Employee Stock Purchase Plan (Incorporated herein by reference to the Registrant’s Annual Report on Form 10-K (File No. 001-34703, Exhibit 10.7.A), filed with the SEC on March 13, 2015).
|
Item 9.
|
Undertakings
|
|
ALIMERA SCIENCES, INC.
|
|
|
|
|
|
By:
|
/s/ C. Daniel Myers
|
|
|
C. Daniel Myers
|
|
|
Chief Executive Officer
|
Signature
|
Title
|
Date
|
/s/ C. Daniel Myers
C. Daniel Myers
|
Chief Executive Officer and Director (Principal Executive Officer)
|
January 6, 2017
|
/s/ Richard S. Eiswirth, Jr.
Richard S. Eiswirth, Jr.
|
President, Chief Financial Officer (Principal Financial and Accounting Officer)
|
January 6, 2017
|
/s/ James Largent
James Largent
|
Chairman of the Board of Directors
|
January 6, 2017
|
/s/ Glen Bradley
Glen Bradley, Ph.D
|
Director
|
January 6, 2017
|
/s/ Mark Brooks
Mark Brooks
|
Director
|
January 6, 2017
|
/s/ Brian K. Halak
Brian K. Halak, Ph.D.
|
Director
|
January 6, 2017
|
/s/ Garheng Kong
Garheng Kong, M.D., Ph.D.
|
Director
|
January 6, 2017
|
/s/ Peter J. Pizzo, III
Peter J. Pizzo, III
|
Director
|
January 6, 2017
|
/s/ Calvin W. Roberts
Calvin W. Roberts, M.D.
|
Director
|
January 6, 2017
|
Exhibit Number
|
Exhibit
|
4.1
|
Restated Certificate of Incorporation of the Registrant (Incorporated herein by reference to Registrant’s Registration Statement on Form S-1/A (File No. 333-162782, Exhibit 3.2) filed with the SEC on April 6, 2010).
|
4.2
|
Amended and Restated Bylaws of the Registrant, as amended (Incorporated herein by reference to Registrant's Current Report (File No. 001-34703, Exhibit 3.1) filed with the SEC on November 5, 2015).
|
4.3
|
Form of Certificate of Designation (Incorporated herein by reference to Registrant’s Current Report (File No. 001-34703, Exhibit 3.5) filed with the SEC on October 2, 2012).
|
4.4
|
Certificate of Designation (Incorporated herein by reference to Registrant’s Current Report (File No. 001-34703, Exhibit 3.6) filed with the SEC on December 15, 2014).
|
4.5
|
Certificate of Amendment to the Restated Certificate of Incorporation of the Registrant.
|
5.1
|
Opinion and consent of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP.
|
23.1
|
Consent of Grant Thornton LLP, Independent Registered Public Accounting Firm.
|
23.2
|
Consent of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is contained in Exhibit 5.1.
|
24.1
|
Power of Attorney. Reference is made to page II-5 of this Registration Statement.
|
99.1
|
Alimera Sciences, Inc. 2010 Equity Incentive Plan (Incorporated herein by reference to Registrant’s Registration Statement on Form S-8 (File No. 333-166822, Exhibit 99.3) filed with the SEC on May 14, 2010).
|
99.2
|
Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan (Incorporated herein by reference to Registrant’s Registration Statement on Form S-8 (File No. 333-166822, Exhibit 99.4) filed with the SEC on May 14, 2010).
|
99.3
|
Amendment No. 1 to 2010 Employee Stock Purchase Plan (Incorporated herein by reference to the Registrant’s Annual Report on Form 10-K (File No. 001-34703, Exhibit 10.7.A), filed with the SEC on March 13, 2015).
|
1 Year Alimera Sciences Chart |
1 Month Alimera Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions